Target intelligence / Profile preview

Novel transcript, antisense to TNFRSF19 (ENSG00000294915)

Target: ENSG00000294915
Molecular classification: Other, Long non-coding RNA (lncRNA)

Overview

Novel transcript, antisense to TNFRSF19" (ENSG00000294915) is a long non-coding RNA (lncRNA) gene annotated in the human genome, transcribed antisense to the protein-coding gene TNFRSF19. No protein product or direct biological function has been assigned, and it is not recognized as a validated therapeutic target. It should not be confused with TNFRSF19 (Tumor necrosis factor receptor superfamily member 19), a receptor protein involved in signaling and development. No interactions, disease involvements, or roles as a biomarker or drug target are described for this lncRNA[7].\n\nKey clarification: \nThe *antisense lncRNA* ENSG00000294915 is genomically distinct from the *protein-coding* TNFRSF19 (which may be a target in some contexts). ENSG00000294915 itself is not a druggable target according to currently available curated data[7].

Other names: Novel transcript, antisense to TNFRSF19ENSG00000294915

Biological functions

Unknown (No validated function available in database searches for this specific transcript[7].)

Disease associations

Unknown (No direct disease associations for the lncRNA. Be aware: TNFRSF19, the sense protein-coding gene, is involved in development and disease but is a different entity[3].)

Beyond the preview

Go deeper on Novel transcript, antisense to TNFRSF19 (ENSG00000294915).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TNFRSF19 (ENSG00000294915).

Explore the full profile